Search Results
O4I1 50mg 50mg | Purity Not Available
Adooq Bioscience
O4I1 increases Oct3/4 mRNA levels in HEK293 cells by 2.5- and 4-fold at 10 uM and 20 uM, respectively.
More Information Supplier PageO4I1 25mg 25mg | Purity Not Available
Adooq Bioscience
O4I1 increases Oct3/4 mRNA levels in HEK293 cells by 2.5- and 4-fold at 10 uM and 20 uM, respectively.
More Information Supplier PageO4I1 10mg 10mg | Purity Not Available
Adooq Bioscience
O4I1 increases Oct3/4 mRNA levels in HEK293 cells by 2.5- and 4-fold at 10 uM and 20 uM, respectively.
More Information Supplier PageZaleplon 50mg 50mg | Purity Not Available
Adooq Bioscience
Zaleplon is a non-benzodiazepine agent that acts as an agonist at the benzodiazepine site.
More Information Supplier PageZaleplon 25mg 25mg | Purity Not Available
Adooq Bioscience
Zaleplon is a non-benzodiazepine agent that acts as an agonist at the benzodiazepine site.
More Information Supplier PageLaninamivir 2mg 2mg | Purity Not Available
Adooq Bioscience
Laninamivir is a neuraminidase inhibitor which is being researched for the treatment and prophylaxis of Influenzavirus A and Influenzavirus B.
More Information Supplier PagePPQ-102 10mg 10mg | Purity Not Available
Adooq Bioscience
PPQ-102 is a compound that targets intracellular nucleotide binding domain(s) of CFTR and inhibits CFTR- mediated chloride current in a voltage-dependent and reversible manner.
More Information Supplier PageINCB024360 analog 5mg 5mg | Purity Not Available
Adooq Bioscience
INCB024360 is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities.
More Information Supplier PageINCB024360 analog 25mg 25mg | Purity Not Available
Adooq Bioscience
INCB024360 is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities.
More Information Supplier Page